Topamax Warning – Increased Risk of Cleft Palate in Newborns


Topamax is a prescription drug originally approved by the FDA in 1996 to treat epilepsy.The generic name is topiramate. Topamax is manufactured by Ortho-McNeil Neurologics, a subsidiary of Johnson & Johnson.

The FDA approved Topamax for use to treat migraines in 2004 and it is often prescribed off-label for bi-polar disorder.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.